Key Statistics
Market Cap$772.82M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.07
52W High$17.65
52W Low$2.95
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees202
Price Performance
1 Week+10.32%
3 Month-29.22%
1 Year+48.10%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$378.27M
Liabilities$403.25M
Net Income$117.81M loss
About
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies, and orphan indications targeting inflammation, complement-mediated diseases, central nervous system (CNS) disorders, and system-related diseases. immunological. The company is headquartered in Seattle, Washington.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze OMER with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.